American Oncology Network, LLC (AON) a high-growth oncology provider partners with the Community Oncology Alliance Patient Advocacy Network (CPAN) helping fight for patients healthcare rights by deploying advocates not just locally but taking the issues directly to Capitol Hill. CPAN is a national advocacy organization committed to raising awareness of independent, community cancer care and the issues that affect

“You’ve got cancer.” That’s one of the scariest sentences in the English language. But it’s less frightening than it used to be. Cancer death rates plummeted 29% between 1991 and 2017, according to the American Cancer Society. Survival rates have soared. Almost 99% of prostate cancer patients are still alive five years after diagnosis, up

In one of the first studies to examine the impact of the COVID-19 pandemic on cancer diagnoses, researchers at Dana-Farber/Brigham and Women’s Cancer Center document a substantial decline in cancer and precancer diagnoses at the Northeast’s largest health care system during the first peak of the pandemic because of a drop in the number of cancer

Only 5 to 10 percent of all cancers are hereditary, but research reveals that family history can increase your chances of developing cancer. Factors that determine your risk include the type of cancer in your family, how old your relatives were when they were diagnosed, and whether other family members have the same type of

The initial batch of COVID-19 vaccines are now available in the U.S. following incredibly fast — “warp speed” — development and testing. Not so incredibly, there’s a lot of confusion among cancer patients — as well as their oncologists and caregivers — as to whether the vaccine is a good idea or a bad idea for

Colorectal cancer (CRC) is the second leading cause of cancer death in the United States. There is compelling evidence that screening to detect CRC early to find and remove precancerous polyps can reduce CRC mortality. However, screening has associated harms, including procedural complications, and inherent limitations. For example, colonoscopy, the most common screening tool in

Exact Sciences Corp. (Nasdaq: EXAS) announced data published today in Cancer Prevention Research, a Journal of the American Association for Cancer Research, that expands on foundational clinical study findings to include a key younger population. Study results show that among average-risk adults between the ages of 45 and 49 Cologuard® (mt-sD­­­­NA) demonstrated test specificity of

The outbreak of the SARS-CoV2 coronavirus that began slowly in Wuhan, China a year ago, before quickly enveloping the world has had widespread, devastating effects on lives, livelihoods and entire economies. Although much focus has rightly centered on the impressive scientific research directly tackling the pandemic, including work tracking the virus, trialing treatments for Covid-19

Genesis Cancer Center (GCC), a partner practice of American Oncology Network, LCC (AON) launches a new chapter of the Community Oncology Alliance Patient Advocacy Network (CPAN). CPAN is a national advocacy organization committed to raising awareness of independent, community cancer care and the issues that affect it. CPAN plays a vital role in advocating for

The death rate from cancer in the U.S. dropped 2.4% from 2017 to 2018, the biggest single-year decline on record and a sign of the impact of new treatments on lung cancer especially, the American Cancer Society said. It was the second year in a row with a record-setting drop, and the progress continues gains